Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection.
SARS-CoV-2
T cells
children
neutralizing antibody
omicron variant
variant of concern
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
08
2022
accepted:
13
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures. Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay. We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children. Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1.
Identifiants
pubmed: 37051428
doi: 10.3389/fped.2023.1020865
pmc: PMC10083310
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1020865Informations de copyright
© 2023 Seidel, Jacobsen, Fabricius, Class, Zernickel, Blum, Conzelmann, Weil, Groß, Bode, Renk, Elling, Stich, Kirchhoff, Debatin, Müench and Janda.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2011;6(10):e25858
pubmed: 21998709
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Front Immunol. 2022 May 17;13:882456
pubmed: 35663948
Cell. 2021 Apr 29;184(9):2384-2393.e12
pubmed: 33794143
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
J Infect Dis. 2022 Jun 1;225(11):1909-1914
pubmed: 34979030
J Immunol Methods. 2008 Nov 30;339(1):23-37
pubmed: 18760281
Nat Commun. 2022 Jan 10;13(1):128
pubmed: 35013206
Emerg Infect Dis. 2021 Dec;27(12):3009-3019
pubmed: 34695369
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Sci Rep. 2018 Nov 9;8(1):16597
pubmed: 30413791
Rev Med Virol. 2022 Sep;32(5):e2381
pubmed: 35856385
EBioMedicine. 2022 Sep;83:104230
pubmed: 35988465
Emerg Microbes Infect. 2022 Dec;11(1):543-547
pubmed: 35084295
Nat Commun. 2022 May 27;13(1):2979
pubmed: 35624101
J Immunol. 2021 Jun 1;206(11):2614-2622
pubmed: 33980583
Nat Commun. 2022 Nov 28;13(1):7315
pubmed: 36437276